Clinical Trial: Anti-MERS-COV Convalescent Plasma Therapy

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional




Official Title: Anti-MERS-COV Convalescent Plasma Therapy

Brief Summary: Since the first report of the Middle East Respiratory Syndrome Corona virus (MERS- CoV) in September 2012, more than 800 cases have been reported to the World Health Organization (WHO) with substantial mortality.